BioCentriq Rebrands as Made Scientific to Redefine Cell Therapy, Defy Limits, and Deliver Results

PRINCETON, N.J., March 17, 2025 /PRNewswire/ -- BioCentriq, a leading cell therapy contract development and manufacturing organization (CDMO), today announced a company rebrand and its new launch as Made Scientific.

The new name, Made Scientific (Manufacturing and Development Excellence), signifies an emboldened mission to accelerate life-saving cell therapies from development to commercialization. The brand reflects a commitment to streamlining complex processes, accelerating timelines, and overcoming scientific and operational hurdles to ensure breakthroughs reach the patients who need them most.

With flexible partnerships, robust technology, deep scientific expertise, and strong leadership, the company is focused on understanding their partners' needs, adapting to challenges, and executing with precision to deliver solutions that make a difference.

"We spent time listening—to startups, established large pharma companies, academic medical centers, biotechs, and scientists pushing the boundaries of cell therapy," said Syed T. Husain, Chairman and CEO of Made Scientific. "The same themes emerged again and again: scalability is a challenge, vendor flexibility is rare, and manufacturing readiness is often an afterthought. We knew that if we could create a CDMO model that addressed these gaps, we'd be solving real problems for innovators."

This announcement follows continued growth and transformation of the business, and the announcement of the company's new headquarters and 60,000 sq. ft., clinical- and commercial-facility in Princeton, NJ – now operational for development programs and GMP services available in Q2 2025.

The facility includes an immediate $12M capital investment in facility upgrades, equipment, and business system enhancements, strengthening Made Scientific's position in the rapidly growing cell therapy sector and enhancing its ability to provide comprehensive development, manufacture, and quality control service solutions in support of its customers' entire product lifecycle. The site features six independent ISO 7 cleanrooms, equipped with cutting-edge analytical and manufacturing technologies, including advanced bioreactors, automated cell processing systems, and scalable production platforms. The facility also offers customizable expansion space to support future growth. The Newark, NJ facility complements these capabilities with Phase I-III manufacturing and also offers hybrid client in plant operations.

Made Scientific offers a comprehensive suite of cell therapy development and manufacturing services, including:

• Process & Analytical Development
• GMP Drug Substance & Product Manufacturing
• GMP Aseptic Fill & Finish
• Quality Control Release Testing & Stability Studies
• Workforce Development & Training

Visit www.madescientific.com to explore the new brand and learn more about its services.

About Made Scientific

Made Scientific is a leading cell therapy contract development and manufacturing organization (CDMO) dedicated to advancing the field of cell therapy. Since 2019, the company has specialized in developing, manufacturing, and releasing autologous and allogeneic cell therapy products for early- to mid-stage clinical trials, and has evolved into an end-to-end clinical-to-commercial service provider. Operating from two U.S.-based manufacturing facilities, Made Scientific combines the flexibility and entrepreneurial spirit of a specialist CDMO with the global expertise and resources of GC Corporation of South Korea, a global leader in the pharmaceutical and biotechnology sectors.

For More Information

Contact [email protected] or follow Made Scientific on LinkedIn.

SOURCE Made Scientific, Inc